BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 12851614)

  • 1. Role of incremental doses of intracoronary adenosine for fractional flow reserve assessment.
    Murtagh B; Higano S; Lennon R; Mathew V; Holmes DR; Lerman A
    Am Heart J; 2003 Jul; 146(1):99-105. PubMed ID: 12851614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adequacy of intracoronary versus intravenous adenosine-induced maximal coronary hyperemia for fractional flow reserve measurements.
    Jeremias A; Whitbourn RJ; Filardo SD; Fitzgerald PJ; Cohen DJ; Tuzcu EM; Anderson WD; Abizaid AA; Mintz GS; Yeung AC; Kern MJ; Yock PG
    Am Heart J; 2000 Oct; 140(4):651-7. PubMed ID: 11011341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve?
    Casella G; Leibig M; Schiele TM; Schrepf R; Seelig V; Stempfle HU; Erdin P; Rieber J; König A; Siebert U; Klauss V
    Am Heart J; 2004 Oct; 148(4):590-5. PubMed ID: 15459587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of 4 doses of intracoronary adenosine in the assessment of fractional flow reserve.
    Casella G; Rieber J; Schiele TM; Stempfle HU; Siebert U; Leibig M; Theisen K; Buchmeier U; Klauss V
    Z Kardiol; 2003 Aug; 92(8):627-32. PubMed ID: 12955409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the intracoronary continuous infusion method using a microcatheter and the intravenous continuous adenosine infusion method for inducing maximal hyperemia for fractional flow reserve measurement.
    Yoon MH; Tahk SJ; Yang HM; Park JS; Zheng M; Lim HS; Choi BJ; Choi SY; Choi UJ; Hwang JW; Kang SJ; Hwang GS; Shin JH
    Am Heart J; 2009 Jun; 157(6):1050-6. PubMed ID: 19464416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of phentolamine on the hyperemic response to adenosine in patients with microvascular disease.
    Aarnoudse W; Geven M; Barbato E; Botman KJ; De Bruyne B; Pijls NH
    Am J Cardiol; 2005 Dec; 96(12):1627-30. PubMed ID: 16360347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of efficacy and safety of intracoronary sodium nitroprusside and intravenous adenosine for assessing fractional flow reserve.
    Rudzinski W; Waller AH; Rusovici A; Dehnee A; Nasur A; Benz M; Sanchez S; Klapholz M; Kaluski E
    Catheter Cardiovasc Interv; 2013 Feb; 81(3):540-4. PubMed ID: 22961876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of coronary fractional flow reserve. Standard doses of intracoronary adenosine are insufficient to induce maximal hyperaemia.
    Rzeczuch K; Jankowska E; Kaczmarek A; Telichowski A; Porada A; Banasiak W; Ponikowski P
    Kardiol Pol; 2003 Apr; 58(4):269-74. PubMed ID: 14517558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of intravenous adenosine to intracoronary papaverine for calculation of pressure-derived fractional flow reserve.
    van der Voort PH; van Hagen E; Hendrix G; van Gelder B; Bech JW; Pijls NH
    Cathet Cardiovasc Diagn; 1996 Oct; 39(2):120-5. PubMed ID: 8922309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of increasing doses of intracoronary adenosine on the assessment of fractional flow reserve.
    De Luca G; Venegoni L; Iorio S; Giuliani L; Marino P
    JACC Cardiovasc Interv; 2011 Oct; 4(10):1079-84. PubMed ID: 22017932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary hyperemic dose responses of intracoronary sodium nitroprusside.
    Parham WA; Bouhasin A; Ciaramita JP; Khoukaz S; Herrmann SC; Kern MJ
    Circulation; 2004 Mar; 109(10):1236-43. PubMed ID: 14993141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incremental doses of intracoronary adenosine for the assessment of coronary velocity reserve for clinical decision making.
    Di Segni E; Higano ST; Rihal CS; Holmes DR; Lennon R; Lerman A
    Catheter Cardiovasc Interv; 2001 Sep; 54(1):34-40. PubMed ID: 11553945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment.
    Verdoia M; Erbetta R; Sagazio E; Barbieri L; Negro F; Suryapranata H; Kedhi E; De Luca G;
    Int J Cardiol; 2019 Jun; 284():16-21. PubMed ID: 30293665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resting Pd/Pa measured with intracoronary pressure wire strongly predicts fractional flow reserve.
    Mamas MA; Horner S; Welch E; Ashworth A; Millington S; Fraser D; Fath-Ordoubadi F; Neyses L; El-Omar M
    J Invasive Cardiol; 2010 Jun; 22(6):260-5. PubMed ID: 20516504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of standard- and high-dose intracoronary adenosine for the measurement of coronary fractional flow reserve (FFR).
    Röther J; Achenbach S; Tröbs M; Blachutzik F; Nef H; Marwan M; Schlundt C
    Clin Res Cardiol; 2016 Dec; 105(12):1003-1010. PubMed ID: 27307094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maximal hyperemia in the assessment of fractional flow reserve: intracoronary adenosine versus intracoronary sodium nitroprusside versus intravenous adenosine: the NASCI (Nitroprussiato versus Adenosina nelle Stenosi Coronariche Intermedie) study.
    Leone AM; Porto I; De Caterina AR; Basile E; Aurelio A; Gardi A; Russo D; Laezza D; Niccoli G; Burzotta F; Trani C; Mazzari MA; Mongiardo R; Rebuzzi AG; Crea F
    JACC Cardiovasc Interv; 2012 Apr; 5(4):402-8. PubMed ID: 22516396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses.
    Courtis J; Rodés-Cabau J; Larose E; Potvin JM; Déry JP; Larochellière RD; Côté M; Cousterousse O; Nguyen CM; Proulx G; Rinfret S; Bertrand OF
    Am J Cardiol; 2009 Apr; 103(7):943-9. PubMed ID: 19327420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of the acute Pd/Pa drop after intracoronary nitroglycerin infusion to rule out significant FFR: CANICA (Can intracoronary nitroglycerin predict fractional flow reserve without adenosine?) multicenter study.
    Martin-Reyes R; de la Torre Hernandez JM; Franco-Pelaez J; Lopez-Palop R; Telleria Arrieta M; Amat Santos IJ; Carrillo Saez P; Sanchez-Recalde A; Sanmartin Pena JC; Garcia Camarero T; Brugaletta S; Gimeno de Carlos F; Pinero A; Sorto Sanchez DC; Frutos A; Lasa Larraya G; Navarro F; Farre J
    Catheter Cardiovasc Interv; 2016 Feb; 87(2):262-9. PubMed ID: 26213338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fractional Flow Reserve in the Transradial Era: Will Hand Vein Adenosine Infusion Suffice?: A Comparative Study of the Extent, Rapidity, and Stability of Hyperemia From Hand and Femoral Venous Routes of Adenosine Administration.
    Scott P; Sirker A; Dworakowski R; Paul G; Candilio L; Jahagirdar N; Melikian N; Byrne J
    JACC Cardiovasc Interv; 2015 Apr; 8(4):527-35. PubMed ID: 25819188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine intracoronary bolus dose escalation versus intravenous infusion to induce maximum coronary hyperemia for fractional flow reserve assessment.
    Legutko J; Kleczyński P; Dziewierz A; Rzeszutko Ł; Dudek D
    Kardiol Pol; 2019 Jun; 77(6):610-617. PubMed ID: 31241047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.